
Steven C. Pohnert
Examiner (ID: 19127, Phone: (571)272-3803 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1683, 1634 |
| Total Applications | 1248 |
| Issued Applications | 108 |
| Pending Applications | 205 |
| Abandoned Applications | 960 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18169119
[patent_doc_number] => 20230035730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/781966
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781966 | SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY | Dec 1, 2020 | Pending |
Array
(
[id] => 18825459
[patent_doc_number] => 11840730
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-12
[patent_title] => Methods and compositions for evaluating genetic markers
[patent_app_type] => utility
[patent_app_number] => 16/952764
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 30089
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952764 | Methods and compositions for evaluating genetic markers | Nov 18, 2020 | Issued |
Array
(
[id] => 17867413
[patent_doc_number] => 20220290149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD OF DETECTION OF FIBRIN CLOTS
[patent_app_type] => utility
[patent_app_number] => 17/770241
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770241 | METHOD OF DETECTION OF FIBRIN CLOTS | Nov 11, 2020 | Abandoned |
Array
(
[id] => 16621900
[patent_doc_number] => 20210040553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/083595
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083595 | OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME | Oct 28, 2020 | Abandoned |
Array
(
[id] => 16778422
[patent_doc_number] => 20210115500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => GENOTYPING EDITED MICROBIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/072449
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072449 | GENOTYPING EDITED MICROBIAL STRAINS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 17082475
[patent_doc_number] => 20210277481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES
[patent_app_type] => utility
[patent_app_number] => 17/061412
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061412 | CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES | Sep 30, 2020 | Abandoned |
Array
(
[id] => 16720482
[patent_doc_number] => 20210087629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Methods for Treating and Detecting Sepsis in Humans
[patent_app_type] => utility
[patent_app_number] => 17/038496
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038496 | Methods for Treating and Detecting Sepsis in Humans | Sep 29, 2020 | Abandoned |
Array
(
[id] => 16728186
[patent_doc_number] => 20210095333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/039956
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/039956 | QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION | Sep 29, 2020 | Abandoned |
Array
(
[id] => 16728204
[patent_doc_number] => 20210095351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Methods of Preparing Dual Indexed Methyl-Seq Libraries
[patent_app_type] => utility
[patent_app_number] => 17/036986
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/036986 | Methods of Preparing Dual Indexed Methyl-Seq Libraries | Sep 28, 2020 | Pending |
Array
(
[id] => 17930146
[patent_doc_number] => 20220325271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/765145
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765145 | DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING | Sep 27, 2020 | Pending |
Array
(
[id] => 16541369
[patent_doc_number] => 20200407782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/012394
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012394 | METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17853120
[patent_doc_number] => 20220283162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/634579
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634579 | MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER | Aug 31, 2020 | Abandoned |
Array
(
[id] => 18666580
[patent_doc_number] => 11773458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Compositions and methods for detection of BK virus
[patent_app_type] => utility
[patent_app_number] => 17/005779
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12147
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005779 | Compositions and methods for detection of BK virus | Aug 27, 2020 | Issued |
Array
(
[id] => 17883093
[patent_doc_number] => 20220298570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => OPTIMIZED NUCLEIC ACID PROBES FOR ANALYTE DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/636403
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636403 | OPTIMIZED NUCLEIC ACID PROBES FOR ANALYTE DETECTION | Aug 19, 2020 | Abandoned |
Array
(
[id] => 16629042
[patent_doc_number] => 20210047695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => CANCER TREATMENTS AND METHODS OF SELECTING SAME
[patent_app_type] => utility
[patent_app_number] => 16/998690
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998690 | CANCER TREATMENTS AND METHODS OF SELECTING SAME | Aug 19, 2020 | Abandoned |
Array
(
[id] => 16614036
[patent_doc_number] => 20210032689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
[patent_app_type] => utility
[patent_app_number] => 16/996180
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996180 | Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations | Aug 17, 2020 | Abandoned |
Array
(
[id] => 16571084
[patent_doc_number] => 20210010090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHOD AND SYSTEM FOR PREDICTING RECURRENCE AND NON-RECURRENCE OF MELANOMA USING SENTINEL LYMPH NODE BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/986324
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986324 | METHOD AND SYSTEM FOR PREDICTING RECURRENCE AND NON-RECURRENCE OF MELANOMA USING SENTINEL LYMPH NODE BIOMARKERS | Aug 5, 2020 | Abandoned |
Array
(
[id] => 16688777
[patent_doc_number] => 20210071253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE
[patent_app_type] => utility
[patent_app_number] => 16/939287
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939287 | HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE | Jul 26, 2020 | Abandoned |
Array
(
[id] => 17274838
[patent_doc_number] => 20210381036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS AND COMPOSITION FOR HIGH THROUGHPUT SINGLE MOLECULE PROTEIN DETECTION SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/938746
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938746 | METHODS AND COMPOSITION FOR HIGH THROUGHPUT SINGLE MOLECULE PROTEIN DETECTION SYSTEMS | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16673507
[patent_doc_number] => 20210062270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => OLIGONUCLEOTIDE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/936618
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936618 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | Jul 22, 2020 | Pending |